Company / Net Income
NovoCure Ltd Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$136.2M
FY2025
5-year range
-$207.0M / $19.8M
FY2021-FY2025
Trend
+19.2%
vs FY2024
Sector context
#136 of 164
Health Care
What the data says
NovoCure Ltd's net income of -$136M is lower than 83% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$207M in FY2023 to $20M in FY2022.
Based on SEC 10-K filings.
-$136M in FY2025.
Improved from -$207M to -$136M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 164This company -$136.2M Sector average $467.5M
▼
-129.1% below sector average
Key checks
Key Insights
- In FY2025, net income increased 19.2% year-over-year.
- Ranks #136 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2022.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$136.2M | +19.2% |
| FY2024 | -$168.6M | +18.6% |
| FY2023 | -$207.0M | -1145.2% |
| FY2022 | $19.8M | +374.0% |
| FY2021 | -$7.2M | +88.6% |
| FY2020 | -$63.6M | -3.1% |
| FY2019 | -$61.7M | +53.2% |
| FY2018 | -$131.8M | -18.2% |
| FY2017 | -$111.6M | -38.3% |
| FY2016 | -$80.7M | -4.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026